Nia Therapeutics develops neural interfaces to restore memory function after brain injury or neurodegenerative disease. Nia’s foundational brain stimulation technology was created at Penn by a team led by Dr. Michael Kahana, the Edmund and Louise Kahn Term Professor of Psychology, with funding from the Defense Advanced Research Projects Agency (DARPA). Their research has shown that when a certain type of precise neurostimulation is delivered to a specific part of the brain it can significantly improve memory performance. Nia was co-founded by Penn and Dr. Kahana, and continues to work closely with PCI. The company has exclusively licensed foundational technology from Penn that was recently awarded an issued patent.
